VYVANSE Side Effects

6706608-2 | Chest Pain
on Dec 03, 2009 Female patient from UNITED STATES , child 9 years of age, weighting 59.97 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). Vyvanse dosage: 20 Mg, 1x/day: Qd, Oral.

6706607-0 | Emotional Distress, Irritability, Muscle Twitching
Patient was taking Vyvanse (View Usage). Patient had the following side effects: emotional distress, irritability, muscle twitching on Jan 06, 2010 from UNITED STATES Additional patient health information: Male patient , 46 years of age, weighting 257.9 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 30 Mg, 1x/day:qd, Oral.

6706590-8 | Chest Pain, Off Label Use
Adverse event was reported on Dec 03, 2009 by a Male patient taking Vyvanse (View Usage) (Dosage: 20 Mg, 1x/day:qd, Oral; 20 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 13 years of age, weighting 104.9 lb, After Vyvanse was administered, patient had the following side effects: chest pain (What is chest pain?), off label use.

6706579-9 | Contusion
on Dec 15, 2009 Female patient from UNITED STATES , child 6 years of age, weighting 35.05 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: contusion. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral. During the same period patient was treated with INTUNIV (1 Mg, 1x/day:qd, Oral) (View Intuniv Review and Intuniv Label ), CHLORAL HYDRATE (CHLORAL HYDRATE) (View Chloral Hydrate (chloral Hydrate) Review and Chloral Hydrate (chloral Hydrate) Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), DEPAKOTE (View Depakote Review and Depakote Label ).


6706566-0 | Blood Glucose Decreased, Insomnia, Sneezing, Tremor
on Jan 06, 2010 Female patient from UNITED STATES , child 6 years of age, weighting 52.91 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: blood glucose decreased, insomnia, sneezing, tremor. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral.

6706565-9 | Off Label Use, Weight Increased
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: off label use, weight increased on Dec 14, 2009 from UNITED STATES Additional patient health information: Female patient , 15 years of age, weighting 179.9 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral.

6706563-5 | Eye Movement Disorder, Off Label Use
Adverse event was reported on Dec 12, 2009 by a Male patient taking Vyvanse (View Usage) (Dosage: 20 Mg, 1x/day:qd, Week Days, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 13 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: eye movement disorder, off label use.

6706561-1 | Alopecia
on Dec 11, 2009 Male patient from UNITED STATES , 26 years of age, was treated with Vyvanse (View Usage). Patient had the following side effects: alopecia. Vyvanse dosage: 50 Mg, Oral.

6706554-4 | Feeling Jittery, Headache, Nervousness
on Dec 13, 2009 Female patient from UNITED STATES , 52 years of age, weighting 200.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: feeling jittery, headache (What is headache?), nervousness. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral.

6706546-5 | Off Label Use, Sleep Disorder
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, sleep disorder (What is sleep disorder?) on Dec 11, 2009 from UNITED STATES Additional patient health information: Male patient , 16 years of age, weighting 110.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral, 40 Mg, 1x/day:qd, Oral. During the same period patient was treated with CELEX /00582602/ (CITALOPRAM HYDROBROMIDE) (View Celex /00582602/ (citalopram Hydrobromide) Review and Celex /00582602/ (citalopram Hydrobromide) Label ).

6706498-8 | Pain In Extremity, Renal Pain
Adverse event was reported on Dec 10, 2009 by a Female patient taking Vyvanse (View Usage) (Dosage: 30 Mg, 1x/day:qd, Oral) . Location: UNITED STATES , 37 years of age, Patient had the following side effects: pain in extremity, renal pain. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ).

6706479-4 | Logorrhoea, Restlessness, Social Avoidant Behaviour
on Dec 19, 2009 Male patient from UNITED STATES , child 6 years of age, weighting 60.01 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: logorrhoea, restlessness, social avoidant behaviour. Vyvanse dosage: 30 Mg, 1x/day;qd, Oral.

6706455-1 | Colitis, Diarrhoea, Irritable Bowel Syndrome, Off Label Use
on Dec 18, 2009 Male patient from UNITED STATES , 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, diarrhoea, irritable bowel syndrome (What is irritable bowel syndrome?), off label use. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), TOFRANIL (View Tofranil Review and Tofranil Label ).

6706453-8 | Alopecia, Off Label Use
Patient was taking Vyvanse (View Usage). Patient had the following side effects: alopecia, off label use on Dec 16, 2009 from UNITED STATES Additional patient health information: Male patient , 16 years of age, . Vyvanse dosage: 50 Mg, Oral.

6706434-4 | Social Avoidant Behaviour
Adverse event was reported on Dec 16, 2009 by a Female patient taking Vyvanse (View Usage) (Dosage: 30 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 6 years of age, weighting 61.95 lb, After Vyvanse was administered, patient had the following side effects: social avoidant behaviour.

6706384-3 | Aggression, Anger, Weight Decreased
on Apr 30, 2010 Male patient from UNITED STATES , 16 years of age, weighting 107.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anger, weight decreased. Vyvanse dosage: 20mg Cap 1x/daily In Morn Po.

6706319-3 | Anxiety, Chills, Eyelid Function Disorder, Fear, Hallucination, Insomnia, Intentional Overdose, Palpitations
on Dec 14, 2009 Male patient from UNITED STATES , 20 years of age, weighting 131.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chills, eyelid function disorder, fear, hallucination, insomnia, intentional overdose, palpitations. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral, 70mg, 1x/day:qd, Oral, Two 70mg. Capsules For Atoal Of 140mg. In Aftern.

6706302-8 | Trismus
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: trismus on Jan 21, 2010 from UNITED STATES Additional patient health information: Male patient , 43 years of age, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 30 Mg, 1x/day;qd, Oral; 20 Mg, 1x/day;qd, Oral.

6706270-9 | Aggression, Anger, Apathy, Frustration, Irritability, Mood Altered
Adverse event was reported on Jan 21, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 30 Mg, 1x/day;qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 8 years of age, weighting 74.08 lb, Patient experienced the following unwanted or unexpected effects: aggression, anger, apathy, frustration, irritability, mood altered.

6706268-0 | Acne, Decreased Appetite, Insomnia, Off Label Use
on Jan 21, 2010 Male patient from UNITED STATES , 16 years of age, weighting 140.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: acne (What is acne?), decreased appetite, insomnia, off label use. Vyvanse dosage: 70 Mg, 1x/day;qd, Oral. During the same period patient was treated with MULTIVITAMIN /00831701/ (VITAMINS NOS) (View Multivitamin /00831701/ (vitamins Nos) Review and Multivitamin /00831701/ (vitamins Nos) Label ).

6706259-X | Depression, Feeling Abnormal, Somnolence
on Jan 20, 2010 Male patient from UNITED STATES , 52 years of age, weighting 224.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: depression (What is depression?), feeling abnormal, somnolence. Vyvanse dosage: 40 Mg, 1x/day;qd, Oral. During the same period patient was treated with LUNESTA (View Lunesta Review and Lunesta Label ).

6706257-6 | Chest Pain, Dyspnoea, Heart Rate Increased
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, heart rate increased on Jan 20, 2010 from UNITED STATES Additional patient health information: Male patient , 18 years of age, . Vyvanse dosage: Mg, 1x/day;qd, Oral.

6706239-4 | Chest Pain, Dyspnoea, Lethargy, Sedation
Adverse event was reported on Jan 19, 2010 by a Female patient taking Vyvanse (View Usage) (Dosage: 30 Mg, 1x/day;qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 8 years of age, Patient had the following side effects: chest pain (What is chest pain?), dyspnoea, lethargy, sedation. During the same period patient was treated with INTUNIV (Mg, 1x/day;qd, Oral; 3 Mg, 1x/day;qd, Oral) (View Intuniv Review and Intuniv Label ).

6706075-9 | Chest Discomfort, Dry Mouth, Headache, Tremor
on Dec 31, 2009 Male patient from UNITED STATES , 40 years of age, weighting 194.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: chest discomfort, dry mouth, headache (What is headache?), tremor. Vyvanse dosage: 40 Mg, 1x/day:qd, Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), FIORINAL (ACETYLSALICYLIC ACID, BUTALBITAL, CAFFEINE, PHENACETIN) (View Fiorinal (acetylsalicylic Acid, Butalbital, Caffeine, Phenacetin) Review and Fiorinal (acetylsalicylic Acid, Butalbital, Caffeine, Phenacetin) Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ).

6706064-4 | Chills, Dizziness, Feeling Cold, Heart Rate Irregular, Palpitations, Sensory Disturbance
on Dec 30, 2009 Female patient from UNITED STATES , 54 years of age, weighting 149.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dizziness (What is dizziness?), feeling cold, heart rate irregular, palpitations, sensory disturbance. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral ; 40 Mg, Takes (2) 20mg Capsules 1x/day:qd, Oral ; 20 Mg, 1x/day:qd, Oral. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ).

6706054-1 | Feeling Drunk, Somnolence
Patient was taking Vyvanse (View Usage). Patient had the following side effects: feeling drunk, somnolence on Dec 28, 2009 from UNITED STATES Additional patient health information: Female patient , 42 years of age, weighting 119.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral.

6706053-X | Disturbance In Attention, Malaise, Off Label Use
Adverse event was reported on Dec 28, 2009 by a Female patient taking Vyvanse (View Usage) (Dosage: 20 Mg, 1x/day:qd, Oral ; 40 Mg, 1x/day:qd Administered As Two 20 Mg Capsules Daily, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 13 years of age, weighting 89.95 lb, After Vyvanse was administered, patient had the following side effects: disturbance in attention, malaise, off label use.

6706050-4 | Off Label Use, Swelling Face
on Dec 24, 2009 Male patient from UNITED STATES , 15 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: off label use, swelling face. Vyvanse dosage: 60 Mg, 1x/day:qd, Oral.

6706049-8 | Abnormal Behaviour, Off Label Use, Product Quality Issue
on Feb 19, 2010 Male patient from UNITED STATES , 13 years of age, weighting 134.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: abnormal behaviour, off label use, product quality issue. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral.

6706046-2 | Decreased Appetite, Disturbance In Social Behaviour, Insomnia, Mood Swings, Tic
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: decreased appetite, disturbance in social behaviour, insomnia, mood swings, tic (What is tic?) on Dec 21, 2009 from UNITED STATES Additional patient health information: Male patient , child 8 years of age, weighting 50.93 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral. During the same period patient was treated with FLONASE (View Flonase Review and Flonase Label ).

6706038-3 | Headache, Migraine
Adverse event was reported on Jan 12, 2010 by a Female patient taking Vyvanse (View Usage) (Dosage: 40 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: headache (What is headache?), migraine (What is migraine?). During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ), ORAL CONTRACEPTIVE NOS (ORAL CONTRACEPTIVE NOS) (View Oral Contraceptive Nos (oral Contraceptive Nos) Review and Oral Contraceptive Nos (oral Contraceptive Nos) Label ).

6706029-2 | Depression, Insomnia, Irritability, Overdose, Paranoia
on Jan 14, 2010 Female patient from UNITED STATES , 30 years of age, was treated with Vyvanse (View Usage). Patient had the following side effects: depression (What is depression?), insomnia, irritability, overdose, paranoia. Vyvanse dosage: 30 Mg, 1x/day:qd, Oral ; 175 Mg, Oral. During the same period patient was treated with XANAX (View Xanax Review and Xanax Label ), LEXAPRO (View Lexapro Review and Lexapro Label ).

6706027-9 | Hypertension, Ocular Vascular Disorder
on Feb 17, 2010 Female patient from UNITED STATES , 57 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: hypertension, ocular vascular disorder. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral : 40 Mg, 1x/day:qd, Oral. During the same period patient was treated with AMBIEN (View Ambien Review and Ambien Label ), WELLBUTRIN XL (View Wellbutrin Xl Review and Wellbutrin Xl Label ), CELEXA (View Celexa Review and Celexa Label ).

6706026-7 | Condition Aggravated, Intraocular Pressure Increased, Off Label Use
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, intraocular pressure increased, off label use on Mar 08, 2010 from UNITED STATES Additional patient health information: Male patient , 14 years of age, weighting 119.9 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 30 Mg, 1x/day:qd, Oral. During the same period patient was treated with PRED FORTE (View Pred Forte Review and Pred Forte Label ), DESMOPRESSIN ACETATE (View Desmopressin Acetate Review and Desmopressin Acetate Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ).

6706017-6 | Crying, Nervousness
Adverse event was reported on Jan 14, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 20 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 6 years of age, weighting 35.05 lb, Patient had the following side effects: crying, nervousness.

6706014-0 | Abdominal Discomfort, Anxiety, Hyperacusis, Malaise, Muscle Tightness
on Jan 13, 2010 Female patient from UNITED STATES , 26 years of age, weighting 125.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: abdominal discomfort, anxiety (What is anxiety?), hyperacusis, malaise, muscle tightness. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral.

6705999-6 | Affect Lability, Decreased Appetite, Dry Mouth, Dyspnoea, Fatigue, Feeling Abnormal, Heart Rate Increased, Insomnia
on Jan 11, 2010 Male patient from UNITED STATES , 47 years of age, weighting 205.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: affect lability, decreased appetite, dry mouth, dyspnoea, fatigue, feeling abnormal, heart rate increased, insomnia. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral;1x/day:qd (^55 Mg^), Oral;1x/day:qd (^57mg^), Oral;50 Mg, 1x/day:qd, Oral. During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), NARCAL (View Narcal Review and Narcal Label ), XANAX (View Xanax Review and Xanax Label ).

6705998-4 | Intervertebral Disc Protrusion, Nervousness, Tremor
Patient was taking Vyvanse (View Usage). Patient had the following side effects: intervertebral disc protrusion, nervousness, tremor on Jan 11, 2010 from UNITED STATES Additional patient health information: Female patient , 33 years of age, weighting 116.0 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral. During the same period patient was treated with ORTHO CEPT (View Ortho-cept Review and Ortho-cept Label ), ALEVE (View Aleve Review and Aleve Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ).

6705996-0 | Rhinorrhoea
Adverse event was reported on Jan 11, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 30 Mg, On School Days, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , child 9 years of age, weighting 59.97 lb, After Vyvanse was administered, patient had the following side effects: rhinorrhoea.

6705979-0 | Therapeutic Response Unexpected
on Jan 11, 2010 Female patient from UNITED STATES , 38 years of age, weighting 257.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: therapeutic response unexpected. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral. During the same period patient was treated with AMARYL (GLIMEPRIRIDE) (View Amaryl (glimepriride) Review and Amaryl (glimepriride) Label ), JANUVIA (View Januvia Review and Januvia Label ), CLARTIN /00413701/ (GLICLAZIDE (View Clartin /00413701/ (gliclazide Review and Clartin /00413701/ (gliclazide Label ), SINGULAIR /01362601/ (MONTELUKAST) (View Singulair /01362601/ (montelukast) Review and Singulair /01362601/ (montelukast) Label ), ALBUTEROL /00139501/ (SALBUTAMOL) (View Albuterol /00139501/ (salbutamol) Review and Albuterol /00139501/ (salbutamol) Label ).

6705977-7 | Burning Sensation, Disorientation, Gingival Pain, Lip Oedema
on Jan 11, 2010 Female patient from UNITED STATES , 54 years of age, was treated with Vyvanse (View Usage). Patient had the following side effects: burning sensation, disorientation, gingival pain, lip oedema. Vyvanse dosage: 50 Mg, 1x/day:qd, Oral, 30 Mg, 1x/day:qd, Oral.

6705973-X | Abdominal Pain Upper, Decreased Appetite, Diarrhoea, Flatulence
Patient was taking Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: abdominal pain upper, decreased appetite, diarrhoea, flatulence on Jan 08, 2010 from UNITED STATES Additional patient health information: Female patient , child 10 years of age, weighting 50.04 lb, . Vyvanse dosage: 40 Mg, 1x/day:qd, Oral, 30 Mg, 1x/day:qd, Oral. During the same period patient was treated with PEDIASURE (CARBOHYDRATES NOS, FATS NOS, MINDRALS NOS, PROTEIN, VITAMIN (View Pediasure (carbohydrates Nos, Fats Nos, Mindrals Nos, Protein, Vitamin Review and Pediasure (carbohydrates Nos, Fats Nos, Mindrals Nos, Protein, Vitamin Label ), PROTIEN SUPPLEMENTS (View Protien Supplements Review and Protien Supplements Label ), FLAXSEED OIL (LINUM USITATISSIMUM SEED OIL) (View Flaxseed Oil (linum Usitatissimum Seed Oil) Review and Flaxseed Oil (linum Usitatissimum Seed Oil) Label ), CELEXA (View Celexa Review and Celexa Label ).

6705853-X | Gait Disturbance, Hypoaesthesia, Incorrect Dose Administered, Off Label Use, Peripheral Coldness
Adverse event was reported on Jan 26, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 50 Mg, 1x/day:qd, Oral, 70 Mg, 1x/day:qd, Oral, 50 Mg, 1x/day:qd, Oral) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , 14 years of age, weighting 160.1 lb, Patient experienced the following unwanted or unexpected effects: gait disturbance, hypoaesthesia, incorrect dose administered, off label use, peripheral coldness. During the same period patient was treated with LUNESTA (View Lunesta Review and Lunesta Label ), AMPICILLIN (View Ampicillin Review and Ampicillin Label ).

6705844-9 | Anxiety, Chest Pain, Heart Rate Increased, Off Label Use
on Jan 06, 2010 Male patient from UNITED STATES , 15 years of age, weighting 140.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chest pain (What is chest pain?), heart rate increased, off label use. Vyvanse dosage: 30 Mg, 2x/day:bid, Oral.

6705842-5 | Excessive Eye Blinking, Mydriasis
on Jan 04, 2010 Male patient from UNITED STATES , child 8 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: excessive eye blinking, mydriasis. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral.

6705836-X | Decreased Appetite, Electrocardiogram Qt Prolonged, Insomnia
Patient was taking Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, electrocardiogram qt prolonged, insomnia on Dec 30, 2009 from UNITED STATES Additional patient health information: Female patient , child 6 years of age, weighting 48.94 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 40 Mg, 1x/day:qd, Oral. During the same period patient was treated with CLARITIN /00413701/ (GLICLAZIDE) (View Claritin /00413701/ (gliclazide) Review and Claritin /00413701/ (gliclazide) Label ).

6704432-8 | Confusional State, Disturbance In Attention, Irritability
Adverse event was reported on Feb 09, 2010 by a Male patient taking Vyvanse (View Usage) (Dosage: 60 Mg, 1x/day:qd, Oral) was diagnosed with attention deficit/hyperactivity disorder and. Location: UNITED STATES , 25 years of age, weighting 162.9 lb, Patient had the following side effects: confusional state, disturbance in attention, irritability. During the same period patient was treated with ZOLOFT /01011401/ (SERTRALINE) TABLET (View Zoloft /01011401/ (sertraline) Tablet Review and Zoloft /01011401/ (sertraline) Tablet Label ).

6704431-6 | Educational Problem, Fatigue, Headache, Insomnia, Mood Altered, Product Quality Issue
on Mar 12, 2010 Male patient from UNITED STATES , child 9 years of age, weighting 63.93 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). After Vyvanse was administered, patient had the following side effects: educational problem, fatigue, headache (What is headache?), insomnia, mood altered, product quality issue. Vyvanse dosage: 20 Mg, 1x/day:qd, Oral.

6704430-4 | No Adverse Event, Theft
on Feb 06, 2010 Male patient from UNITED STATES , 26 years of age, weighting 179.9 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Vyvanse (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event, theft. Vyvanse dosage: 70 Mg, 1x/day:qd, Oral. During the same period patient was treated with KLONOPIN (View Klonopin Review and Klonopin Label ), PROZAC (View Prozac Review and Prozac Label ).

6704429-8 | Anger, Change In Sustained Attention, Incorrect Dose Administered, Insomnia, Mood Altered
Patient was taking Vyvanse (View Usage). Patient had the following side effects: anger, change in sustained attention, incorrect dose administered, insomnia, mood altered on Mar 18, 2010 from UNITED STATES Additional patient health information: Male patient , child 10 years of age, weighting 80.03 lb, was diagnosed with attention deficit/hyperactivity disorder and. Vyvanse dosage: 30 Mg, 1x/day:qd, Oral, 20 Mg, 1xday;qd, Oral, Half 20mg Capsule, 1x/day:qd, Oral.